<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Resistance Mechanisms - Detailed</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: #f0f2f5;
            padding: 20px;
        }
        
        .slide {
            width: 960px;
            min-height: 540px;
            padding: 40px;
            background: white;
            margin: 0 auto 30px;
            border-radius: 8px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
            page-break-after: always;
        }
        
        .title {
            font-size: 32px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 20px;
            text-align: center;
            border-bottom: 3px solid #1E64C8;
            padding-bottom: 15px;
        }
        
        .subtitle {
            font-size: 24px;
            font-weight: 600;
            color: #1E64C8;
            margin-bottom: 20px;
            text-align: center;
        }
        
        .diagram-container {
            display: flex;
            justify-content: center;
            align-items: center;
            margin-bottom: 20px;
            position: relative;
            height: 320px;
            background: #f8f9fb;
            border-radius: 12px;
            padding: 20px;
        }
        
        .mechanism-svg {
            width: 100%;
            height: 100%;
        }
        
        .detail-svg {
            width: 100%;
            height: 350px;
        }
        
        .target-cell {
            fill: url(#targetGradient);
            stroke: white;
            stroke-width: 3;
            filter: drop-shadow(0 6px 12px rgba(30, 100, 200, 0.3));
        }
        
        .drug-molecule {
            fill: #4CAF50;
            stroke: white;
            stroke-width: 2;
            animation: approach 3s ease-in-out infinite;
        }
        
        @keyframes approach {
            0%, 100% { transform: translate(0, 0); }
            50% { transform: translate(-10px, 0); }
        }
        
        .blocked-drug {
            fill: #ff6b6b;
            stroke: white;
            stroke-width: 2;
            opacity: 0.8;
        }
        
        .resistance-barrier {
            stroke: #ff6b6b;
            stroke-width: 3;
            fill: none;
            stroke-dasharray: 8,4;
            opacity: 0.7;
            animation: pulse 2s ease-in-out infinite;
        }
        
        @keyframes pulse {
            0%, 100% { stroke-width: 3; opacity: 0.7; }
            50% { stroke-width: 4; opacity: 0.9; }
        }
        
        .mutation-marker {
            fill: #ffa500;
            stroke: white;
            stroke-width: 2;
            animation: blink 2s ease-in-out infinite;
        }
        
        @keyframes blink {
            0%, 100% { opacity: 1; }
            50% { opacity: 0.5; }
        }
        
        .bypass-pathway {
            stroke: #ff9f6b;
            stroke-width: 2.5;
            fill: none;
            stroke-dasharray: 10,5;
            marker-end: url(#bypassArrow);
            animation: flow 3s linear infinite;
        }
        
        @keyframes flow {
            to { stroke-dashoffset: -15; }
        }
        
        .mechanism-label {
            fill: #333;
            font-size: 13px;
            font-weight: 600;
        }
        
        .receptor {
            fill: #5088d4;
            stroke: white;
            stroke-width: 2;
        }
        
        .signal-path {
            stroke: #1E64C8;
            stroke-width: 2;
            fill: none;
            opacity: 0.6;
        }
        
        .signal-blocked {
            stroke: #ff6b6b;
            stroke-width: 2;
            fill: none;
            stroke-dasharray: 5,5;
            opacity: 0.8;
        }
        
        .efflux-pump {
            fill: #ff6b6b;
            stroke: white;
            stroke-width: 2;
            animation: rotate 4s linear infinite;
            transform-origin: center;
        }
        
        @keyframes rotate {
            from { transform: rotate(0deg); }
            to { transform: rotate(360deg); }
        }
        
        .mechanism-box {
            fill: white;
            stroke: #1E64C8;
            stroke-width: 2;
            rx: 8;
        }
        
        .primary-box {
            fill: #ffe8e8;
        }
        
        .acquired-box {
            fill: #fff8e8;
        }
        
        .combo-box {
            fill: #e8f8e8;
        }
        
        .icon-text {
            font-size: 20px;
        }
        
        .highlight-box {
            background: linear-gradient(135deg, #1E64C8 0%, #5088d4 100%);
            color: white;
            padding: 16px 25px;
            border-radius: 10px;
            text-align: center;
            font-size: 15px;
            font-weight: 500;
            line-height: 1.6;
        }
        
        .dna-helix {
            stroke: #1E64C8;
            stroke-width: 2;
            fill: none;
            stroke-linecap: round;
        }
        
        .content-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 20px;
            margin-top: 20px;
        }
        
        .detail-box {
            background: #f8f9fb;
            padding: 20px;
            border-radius: 10px;
            border-left: 4px solid #1E64C8;
        }
        
        .detail-box.primary {
            border-left-color: #ff6b6b;
        }
        
        .detail-box.acquired {
            border-left-color: #ffa500;
        }
        
        .detail-box.bypass {
            border-left-color: #ff9f6b;
        }
        
        .detail-box.combo {
            border-left-color: #4CAF50;
        }
        
        .detail-box h3 {
            color: #1E64C8;
            font-size: 18px;
            margin-bottom: 12px;
        }
        
        .detail-box ul {
            list-style: none;
            padding-left: 0;
        }
        
        .detail-box li {
            padding: 8px 0;
            padding-left: 24px;
            position: relative;
            line-height: 1.6;
            font-size: 14px;
        }
        
        .detail-box li:before {
            content: "â–¸";
            position: absolute;
            left: 0;
            color: #1E64C8;
            font-weight: bold;
        }
        
        .example-box {
            background: #fff9e6;
            padding: 15px;
            border-radius: 8px;
            margin-top: 15px;
            border: 2px solid #ffd700;
        }
        
        .example-box h4 {
            color: #ff8c00;
            font-size: 15px;
            margin-bottom: 8px;
        }
        
        .example-box p {
            font-size: 13px;
            line-height: 1.5;
            color: #333;
        }
        
        .membrane {
            fill: none;
            stroke: #666;
            stroke-width: 3;
        }
        
        .cell-interior {
            fill: #e3f2fd;
            opacity: 0.3;
        }
        
        .arrow {
            stroke: #333;
            stroke-width: 2;
            fill: none;
            marker-end: url(#arrowhead);
        }
        
        .drug-active {
            fill: #4CAF50;
        }
        
        .drug-inactive {
            fill: #ff6b6b;
        }
        
        .enzyme {
            fill: #9c27b0;
            stroke: white;
            stroke-width: 2;
        }
        
        .mutated-receptor {
            fill: #ff6b6b;
            stroke: white;
            stroke-width: 2;
        }
        
        .normal-receptor {
            fill: #4CAF50;
            stroke: white;
            stroke-width: 2;
        }
        
        @media print {
            body {
                background: white;
                padding: 0;
            }
            .slide {
                box-shadow: none;
                margin: 0;
                page-break-after: always;
            }
        }
    </style>
</head>
<body>
    <!-- Slide 1: Overview -->
    <div class="slide">
        <div class="title">Resistance Mechanisms</div>
        
        <div class="diagram-container">
            <svg class="mechanism-svg" viewBox="0 0 900 320">
                <defs>
                    <marker id="bypassArrow" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                        <polygon points="0 0, 10 3, 0 6" fill="#ff9f6b" />
                    </marker>
                    <linearGradient id="targetGradient" x1="0%" y1="0%" x2="0%" y2="100%">
                        <stop offset="0%" style="stop-color:#5088d4;stop-opacity:1" />
                        <stop offset="100%" style="stop-color:#1E64C8;stop-opacity:1" />
                    </linearGradient>
                </defs>
                
                <!-- Central cancer cell -->
                <g transform="translate(450, 160)">
                    <circle class="target-cell" cx="0" cy="0" r="60"/>
                    
                    <!-- Nucleus -->
                    <circle cx="0" cy="0" r="25" fill="white" opacity="0.8"/>
                    
                    <!-- DNA with mutations -->
                    <path class="dna-helix" d="M-15,-10 Q-5,-15 5,-10 T15,-10"/>
                    <path class="dna-helix" d="M-15,0 Q-5,5 5,0 T15,0"/>
                    <circle class="mutation-marker" cx="0" cy="-5" r="4"/>
                    
                    <text class="mechanism-label" x="0" y="80" text-anchor="middle">Cancer Cell</text>
                </g>
                
                <!-- Primary Resistance -->
                <g transform="translate(150, 80)">
                    <rect class="mechanism-box primary-box" x="-80" y="-30" width="160" height="60"/>
                    <text class="icon-text" x="-60" y="5" text-anchor="middle">ðŸ”’</text>
                    <text class="mechanism-label" x="10" y="-10" text-anchor="middle">Primary Resistance</text>
                    <text class="mechanism-label" x="10" y="5" text-anchor="middle" font-size="11" opacity="0.8">Intrinsic factors</text>
                    <text class="mechanism-label" x="10" y="20" text-anchor="middle" font-size="11" opacity="0.8">Pre-existing</text>
                    
                    <!-- Drug molecules blocked -->
                    <circle class="blocked-drug" cx="120" cy="0" r="8"/>
                    <line x1="105" y1="-15" x2="135" y2="15" stroke="#ff6b6b" stroke-width="3"/>
                    <line x1="105" y1="15" x2="135" y2="-15" stroke="#ff6b6b" stroke-width="3"/>
                    
                    <!-- Connection to cell -->
                    <path class="signal-blocked" d="M80,20 L350,120"/>
                </g>
                
                <!-- Acquired Resistance -->
                <g transform="translate(150, 240)">
                    <rect class="mechanism-box acquired-box" x="-80" y="-30" width="160" height="60"/>
                    <text class="icon-text" x="-60" y="5" text-anchor="middle">ðŸ”„</text>
                    <text class="mechanism-label" x="10" y="-10" text-anchor="middle">Acquired Resistance</text>
                    <text class="mechanism-label" x="10" y="5" text-anchor="middle" font-size="11" opacity="0.8">Adaptive changes</text>
                    <text class="mechanism-label" x="10" y="20" text-anchor="middle" font-size="11" opacity="0.8">During therapy</text>
                    
                    <!-- Efflux pump visualization -->
                    <g transform="translate(120, 0)">
                        <circle class="efflux-pump" cx="0" cy="0" r="12"/>
                        <path d="M-8,0 L0,-8 L8,0 L0,8 Z" fill="white"/>
                    </g>
                    
                    <!-- Connection to cell -->
                    <path class="signal-blocked" d="M80,-20 L350,200"/>
                </g>
                
                <!-- Bypass Pathways -->
                <g transform="translate(750, 80)">
                    <rect class="mechanism-box acquired-box" x="-80" y="-30" width="160" height="60"/>
                    <text class="icon-text" x="-60" y="5" text-anchor="middle">ðŸ”€</text>
                    <text class="mechanism-label" x="10" y="-10" text-anchor="middle">Bypass Pathways</text>
                    <text class="mechanism-label" x="10" y="5" text-anchor="middle" font-size="11" opacity="0.8">Alternative routes</text>
                    <text class="mechanism-label" x="10" y="20" text-anchor="middle" font-size="11" opacity="0.8">Signal redundancy</text>
                    
                    <!-- Bypass pathway visualization -->
                    <path class="bypass-pathway" d="M-100,0 Q-120,40 -100,80 Q-80,100 -60,80"/>
                    
                    <!-- Connection from cell -->
                    <path class="signal-path" d="M550,120 L670,80"/>
                </g>
                
                <!-- Combination Strategy -->
                <g transform="translate(750, 240)">
                    <rect class="mechanism-box combo-box" x="-80" y="-30" width="160" height="60"/>
                    <text class="icon-text" x="-60" y="5" text-anchor="middle">ðŸ’Š</text>
                    <text class="mechanism-label" x="10" y="-10" text-anchor="middle">Combination Strategy</text>
                    <text class="mechanism-label" x="10" y="5" text-anchor="middle" font-size="11" opacity="0.8">Multi-target</text>
                    <text class="mechanism-label" x="10" y="20" text-anchor="middle" font-size="11" opacity="0.8">Prevent escape</text>
                    
                    <!-- Multiple drugs -->
                    <circle class="drug-molecule" cx="-100" cy="-10" r="6"/>
                    <circle class="drug-molecule" cx="-100" cy="0" r="6" fill="#5088d4"/>
                    <circle class="drug-molecule" cx="-100" cy="10" r="6" fill="#ffa500"/>
                    
                    <!-- Connection from cell -->
                    <path class="signal-path" d="M550,200 L670,240"/>
                </g>
                
                <!-- Resistance barrier around cell -->
                <circle class="resistance-barrier" cx="450" cy="160" r="85"/>
                
                <!-- Receptors on cell surface -->
                <g transform="translate(450, 160)">
                    <rect class="receptor" x="-65" y="-5" width="10" height="20" rx="2"/>
                    <rect class="receptor" x="55" y="-5" width="10" height="20" rx="2"/>
                    <rect class="receptor" x="-5" y="-65" width="20" height="10" rx="2" transform="rotate(90 0 0)"/>
                    <rect class="receptor" x="-5" y="55" width="20" height="10" rx="2" transform="rotate(90 0 0)"/>
                </g>
                
                <!-- Floating drug molecules -->
                <g class="drug-molecule" transform="translate(320, 100)">
                    <circle cx="0" cy="0" r="8"/>
                    <text x="0" y="3" fill="white" font-size="10" text-anchor="middle">D1</text>
                </g>
                
                <g class="drug-molecule" transform="translate(580, 100)" style="animation-delay: 1s">
                    <circle cx="0" cy="0" r="8"/>
                    <text x="0" y="3" fill="white" font-size="10" text-anchor="middle">D2</text>
                </g>
                
                <g class="drug-molecule" transform="translate(320, 220)" style="animation-delay: 2s">
                    <circle cx="0" cy="0" r="8"/>
                    <text x="0" y="3" fill="white" font-size="10" text-anchor="middle">D3</text>
                </g>
            </svg>
        </div>
        
        <div class="highlight-box">
            Monitoring Approaches: Serial biopsies and liquid biopsy track resistance evolution
        </div>
    </div>

    <!-- Slide 2: Primary Resistance -->
    <div class="slide">
        <div class="subtitle">Primary (Intrinsic) Resistance</div>
        
        <div class="diagram-container">
            <svg class="detail-svg" viewBox="0 0 800 350">
                <defs>
                    <marker id="arrowhead" markerWidth="10" markerHeight="7" refX="9" refY="3.5" orient="auto">
                        <polygon points="0 0, 10 3.5, 0 7" fill="#333" />
                    </marker>
                </defs>
                
                <!-- Cell membrane -->
                <ellipse cx="400" cy="175" rx="250" ry="140" class="cell-interior"/>
                <ellipse cx="400" cy="175" rx="250" ry="140" class="membrane"/>
                
                <!-- Title -->
                <text x="400" y="30" text-anchor="middle" font-size="18" font-weight="bold" fill="#ff6b6b">Pre-existing Resistance Factors</text>
                
                <!-- Mechanism 1: Target Mutation -->
                <g transform="translate(150, 120)">
                    <rect class="mutated-receptor" x="-20" y="-30" width="40" height="60" rx="5"/>
                    <text x="0" y="-5" text-anchor="middle" fill="white" font-size="16">X</text>
                    <text x="0" y="80" text-anchor="middle" font-size="13" font-weight="600">Mutated Target</text>
                    
                    <!-- Drug unable to bind -->
                    <circle class="blocked-drug" cx="-60" cy="0" r="12"/>
                    <line x1="-75" y1="-15" x2="-45" y2="15" stroke="#ff6b6b" stroke-width="3"/>
                    <line x1="-75" y1="15" x2="-45" y2="-15" stroke="#ff6b6b" stroke-width="3"/>
                </g>
                
                <!-- Mechanism 2: Low Expression -->
                <g transform="translate(400, 120)">
                    <rect class="receptor" x="-15" y="-25" width="30" height="50" rx="5" opacity="0.3"/>
                    <text x="0" y="60" text-anchor="middle" font-size="13" font-weight="600">Low Target</text>
                    <text x="0" y="78" text-anchor="middle" font-size="13" font-weight="600">Expression</text>
                    
                    <!-- Few receptors -->
                    <rect class="receptor" x="-45" y="-15" width="20" height="30" rx="3" opacity="0.2"/>
                    <rect class="receptor" x="25" y="-15" width="20" height="30" rx="3" opacity="0.2"/>
                </g>
                
                <!-- Mechanism 3: Efflux Pumps -->
                <g transform="translate(650, 120)">
                    <g class="efflux-pump" transform="translate(0, 0)">
                        <rect x="-20" y="-35" width="40" height="70" rx="5"/>
                        <path d="M-12,0 L0,-15 L12,0 L0,15 Z" fill="white"/>
                    </g>
                    <text x="0" y="70" text-anchor="middle" font-size="13" font-weight="600">Efflux Pumps</text>
                    
                    <!-- Drug being pumped out -->
                    <circle class="blocked-drug" cx="0" cy="-60" r="10"/>
                    <path class="arrow" d="M0,-50 L0,-70" marker-end="url(#arrowhead)"/>
                </g>
                
                <!-- Bottom explanation -->
                <text x="400" y="280" text-anchor="middle" font-size="14" fill="#666">Genetic factors present before treatment initiation</text>
            </svg>
        </div>
        
        <div class="content-grid">
            <div class="detail-box primary">
                <h3>Key Characteristics</h3>
                <ul>
                    <li>Pre-existing in tumor cells before treatment</li>
                    <li>Germline or somatic mutations present at diagnosis</li>
                    <li>Tumor heterogeneity with resistant subclones</li>
                    <li>Immediate treatment failure or minimal response</li>
                </ul>
            </div>
            
            <div class="detail-box primary">
                <h3>Mechanisms</h3>
                <ul>
                    <li>Target gene mutations preventing drug binding</li>
                    <li>Low or absent target protein expression</li>
                    <li>High expression of drug efflux transporters</li>
                    <li>Pre-existing bypass pathway activation</li>
                </ul>
            </div>
        </div>
        
        <div class="example-box">
            <h4>Clinical Example</h4>
            <p><strong>EGFR-mutant NSCLC with T790M:</strong> Approximately 60% of EGFR-mutant non-small cell lung cancers that develop resistance to first-generation EGFR TKIs (erlotinib, gefitinib) harbor the T790M gatekeeper mutation, which increases ATP affinity and prevents drug binding.</p>
        </div>
    </div>

    <!-- Slide 3: Acquired Resistance -->
    <div class="slide">
        <div class="subtitle">Acquired Resistance</div>
        
        <div class="diagram-container">
            <svg class="detail-svg" viewBox="0 0 800 350">
                <!-- Timeline showing progression -->
                <line x1="50" y1="50" x2="750" y2="50" stroke="#1E64C8" stroke-width="3"/>
                
                <!-- Time point 1: Treatment Start -->
                <g transform="translate(150, 50)">
                    <circle cx="0" cy="0" r="10" fill="#4CAF50"/>
                    <text x="0" y="-25" text-anchor="middle" font-size="13" font-weight="600">Treatment Start</text>
                    
                    <!-- Sensitive cell -->
                    <circle cx="0" cy="80" r="40" fill="#4CAF50" opacity="0.7" stroke="white" stroke-width="2"/>
                    <text x="0" y="85" text-anchor="middle" fill="white" font-weight="600">Sensitive</text>
                    <rect class="normal-receptor" x="-30" y="60" width="15" height="25" rx="3"/>
                    <rect class="normal-receptor" x="15" y="60" width="15" height="25" rx="3"/>
                </g>
                
                <!-- Arrow -->
                <path d="M200,50 L350,50" stroke="#1E64C8" stroke-width="2" marker-end="url(#arrowhead)"/>
                <text x="275" y="40" text-anchor="middle" font-size="12" fill="#666">Drug Pressure</text>
                
                <!-- Time point 2: Evolution -->
                <g transform="translate(400, 50)">
                    <circle cx="0" cy="0" r="10" fill="#ffa500"/>
                    <text x="0" y="-25" text-anchor="middle" font-size="13" font-weight="600">Selection</text>
                    
                    <!-- Mutating cell -->
                    <circle cx="0" cy="80" r="40" fill="#ffa500" opacity="0.7" stroke="white" stroke-width="2"/>
                    <circle class="mutation-marker" cx="-10" cy="70" r="6"/>
                    <circle class="mutation-marker" cx="10" cy="70" r="6"/>
                    <text x="0" y="150" text-anchor="middle" font-size="11">Mutation</text>
                </g>
                
                <!-- Arrow -->
                <path d="M450,50 L600,50" stroke="#1E64C8" stroke-width="2" marker-end="url(#arrowhead)"/>
                <text x="525" y="40" text-anchor="middle" font-size="12" fill="#666">Clonal Expansion</text>
                
                <!-- Time point 3: Resistance -->
                <g transform="translate(650, 50)">
                    <circle cx="0" cy="0" r="10" fill="#ff6b6b"/>
                    <text x="0" y="-25" text-anchor="middle" font-size="13" font-weight="600">Progression</text>
                    
                    <!-- Resistant cell -->
                    <circle cx="0" cy="80" r="40" fill="#ff6b6b" opacity="0.7" stroke="white" stroke-width="2"/>
                    <text x="0" y="85" text-anchor="middle" fill="white" font-weight="600">Resistant</text>
                    <rect class="mutated-receptor" x="-30" y="60" width="15" height="25" rx="3"/>
                    <rect class="mutated-receptor" x="15" y="60" width="15" height="25" rx="3"/>
                </g>
                
                <!-- Bottom section: Mechanisms -->
                <g transform="translate(0, 200)">
                    <text x="400" y="0" text-anchor="middle" font-size="16" font-weight="bold" fill="#ffa500">Adaptive Mechanisms During Therapy</text>
                    
                    <!-- Mechanism boxes -->
                    <g transform="translate(100, 30)">
                        <rect x="0" y="0" width="140" height="80" rx="8" fill="#fff8e8" stroke="#ffa500" stroke-width="2"/>
                        <text x="70" y="25" text-anchor="middle" font-size="12" font-weight="600">Secondary</text>
                        <text x="70" y="40" text-anchor="middle" font-size="12" font-weight="600">Mutations</text>
                        <text x="70" y="60" text-anchor="middle" font-size="10">Target alterations</text>
                        <text x="70" y="73" text-anchor="middle" font-size="10">Downstream changes</text>
                    </g>
                    
                    <g transform="translate(260, 30)">
                        <rect x="0" y="0" width="140" height="80" rx="8" fill="#fff8e8" stroke="#ffa500" stroke-width="2"/>
                        <text x="70" y="25" text-anchor="middle" font-size="12" font-weight="600">Gene</text>
                        <text x="70" y="40" text-anchor="middle" font-size="12" font-weight="600">Amplification</text>
                        <text x="70" y="60" text-anchor="middle" font-size="10">MET amplification</text>
                        <text x="70" y="73" text-anchor="middle" font-size="10">HER2 amplification</text>
                    </g>
                    
                    <g transform="translate(420, 30)">
                        <rect x="0" y="0" width="140" height="80" rx="8" fill="#fff8e8" stroke="#ffa500" stroke-width="2"/>
                        <text x="70" y="25" text-anchor="middle" font-size="12" font-weight="600">Phenotypic</text>
                        <text x="70" y="40" text-anchor="middle" font-size="12" font-weight="600">Changes</text>
                        <text x="70" y="60" text-anchor="middle" font-size="10">EMT transition</text>
                        <text x="70" y="73" text-anchor="middle" font-size="10">Histologic shifts</text>
                    </g>
                </g>
            </svg>
        </div>
        
        <div class="content-grid">
            <div class="detail-box acquired">
                <h3>Key Characteristics</h3>
                <ul>
                    <li>Develops during treatment exposure</li>
                    <li>Initial response followed by progression</li>
                    <li>Clonal selection under drug pressure</li>
                    <li>Time to resistance: months to years</li>
                </ul>
            </div>
            
            <div class="detail-box acquired">
                <h3>Common Mechanisms</h3>
                <ul>
                    <li>On-target: Secondary mutations in target gene</li>
                    <li>Off-target: Parallel pathway activation</li>
                    <li>Drug metabolism: Increased efflux, decreased uptake</li>
                    <li>Histologic transformation: SCLC conversion</li>
                </ul>
            </div>
        </div>
        
        <div class="example-box">
            <h4>Clinical Example</h4>
            <p><strong>Osimertinib Resistance in EGFR T790M+ NSCLC:</strong> C797S mutation emerges in approximately 15-30% of patients treated with osimertinib (third-generation EGFR TKI), preventing covalent drug binding. MET amplification accounts for another 15-20% of resistance mechanisms.</p>
        </div>
    </div>

    <!-- Slide 4: Bypass Pathways -->
    <div class="slide">
        <div class="subtitle">Bypass Pathway Activation</div>
        
        <div class="diagram-container">
            <svg class="detail-svg" viewBox="0 0 800 350">
                <!-- Normal signaling -->
                <g transform="translate(150, 50)">
                    <text x="0" y="0" font-size="15" font-weight="bold" fill="#4CAF50">Normal Signaling</text>
                    
                    <!-- Receptor -->
                    <rect class="normal-receptor" x="-15" y="30" width="30" height="50" rx="5"/>
                    <text x="0" y="100" text-anchor="middle" font-size="11" font-weight="600">EGFR</text>
                    
                    <!-- Linear pathway -->
                    <circle cx="0" cy="140" r="15" fill="#5088d4" stroke="white" stroke-width="2"/>
                    <text x="0" y="145" text-anchor="middle" fill="white" font-size="10" font-weight="600">RAS</text>
                    
                    <path class="arrow" d="M0,80 L0,125" marker-end="url(#arrowhead)"/>
                    
                    <circle cx="0" cy="190" r="15" fill="#5088d4" stroke="white" stroke-width="2"/>
                    <text x="0" y="195" text-anchor="middle" fill="white" font-size="10" font-weight="600">RAF</text>
                    
                    <path class="arrow" d="M0,155 L0,175" marker-end="url(#arrowhead)"/>
                    
                    <circle cx="0" cy="240" r="15" fill="#5088d4" stroke="white" stroke-width="2"/>
                    <text x="0" y="245" text-anchor="middle" fill="white" font-size="10" font-weight="600">MEK</text>
                    
                    <path class="arrow" d="M0,205 L0,225" marker-end="url(#arrowhead)"/>
                    
                    <circle cx="0" cy="290" r="15" fill="#5088d4" stroke="white" stroke-width="2"/>
                    <text x="0" y="295" text-anchor="middle" fill="white" font-size="10" font-weight="600">ERK</text>
                    
                    <path class="arrow" d="M0,255 L0,275" marker-end="url(#arrowhead)"/>
                </g>
                
                <!-- Drug block -->
                <g transform="translate(300, 175)">
                    <rect x="-50" y="-40" width="100" height="80" rx="10" fill="#ff6b6b" opacity="0.2" stroke="#ff6b6b" stroke-width="3"/>
                    <text x="0" y="-50" text-anchor="middle" font-size="14" font-weight="bold" fill="#ff6b6b">Drug Block</text>
                    <circle class="drug-molecule" cx="0" cy="0" r="15"/>
                    <text x="0" y="5" text-anchor="middle" fill="white" font-size="11" font-weight="600">TKI</text>
                </g>
                
                <!-- Arrow indicating resistance -->
                <path d="M250,175 L450,175" stroke="#ff6b6b" stroke-width="3" marker-end="url(#arrowhead)" stroke-dasharray="10,5"/>
                <text x="350" y="165" text-anchor="middle" font-size="13" font-weight="bold" fill="#ff6b6b">Resistance</text>
                
                <!-- Bypass pathways -->
                <g transform="translate(650, 50)">
                    <text x="-50" y="0" font-size="15" font-weight="bold" fill="#ff9f6b">Bypass Activation</text>
                    
                    <!-- Multiple receptors -->
                    <rect class="mutated-receptor" x="-65" y="30" width="30" height="50" rx="5"/>
                    <text x="-50" y="100" text-anchor="middle" font-size="11" font-weight="600">EGFR</text>
                    <line x1="-65" y1="40" x2="-35" y2="70" stroke="#ff6b6b" stroke-width="3"/>
                    <line x1="-65" y1="70" x2="-35" y2="40" stroke="#ff6b6b" stroke-width="3"/>
                    
                    <rect class="normal-receptor" x="-15" y="30" width="30" height="50" rx="5"/>
                    <text x="0" y="100" text-anchor="middle" font-size="11" font-weight="600">MET</text>
                    
                    <rect class="normal-receptor" x="35" y="30" width="30" height="50" rx="5"/>
                    <text x="50" y="100" text-anchor="middle" font-size="11" font-weight="600">HER2</text>
                    
                    <!-- Converging pathways -->
                    <circle cx="0" cy="140" r="15" fill="#ff9f6b" stroke="white" stroke-width="2"/>
                    <text x="0" y="145" text-anchor="middle" fill="white" font-size="10" font-weight="600">RAS</text>
                    
                    <path class="bypass-pathway" d="M-50,80 Q-50,110 0,125"/>
                    <path class="arrow" d="M0,80 L0,125" stroke="#5088d4" stroke-width="2" marker-end="url(#arrowhead)"/>
                    <path class="bypass-pathway" d="M50,80 Q50,110 0,125"/>
                    
                    <circle cx="0" cy="190" r="15" fill="#ff9f6b" stroke="white" stroke-width="2"/>
                    <text x="0" y="195" text-anchor="middle" fill="white" font-size="10" font-weight="600">PI3K</text>
                    
                    <path class="arrow" d="M0,155 L0,175" marker-end="url(#arrowhead)"/>
                    
                    <rect x="-30" y="220" width="60" height="30" rx="5" fill="#4CAF50" stroke="white" stroke-width="2"/>
                    <text x="0" y="240" text-anchor="middle" fill="white" font-size="11" font-weight="600">Survival</text>
                    
                    <path class="arrow" d="M0,205 L0,220" marker-end="url(#arrowhead)"/>
                </g>
            </svg>
        </div>
        
        <div class="content-grid">
            <div class="detail-box bypass">
                <h3>Key Characteristics</h3>
                <ul>
                    <li>Alternative pathways maintain signaling output</li>
                    <li>Signal redundancy overcomes single-target inhibition</li>
                    <li>Can be pre-existing or acquired during treatment</li>
                    <li>Often involves parallel RTK activation</li>
                </ul>
            </div>
            
            <div class="detail-box bypass">
                <h3>Common Bypass Routes</h3>
                <ul>
                    <li>MET amplification bypassing EGFR inhibition</li>
                    <li>HER2/HER3 activation maintaining PI3K signaling</li>
                    <li>IGF-1R upregulation in hormone receptor+ breast cancer</li>
                    <li>PIK3CA mutations activating downstream signaling</li>
                </ul>
            </div>
        </div>
        
        <div class="example-box">
            <h4>Clinical Example</h4>
            <p><strong>MET Amplification in EGFR-mutant NSCLC:</strong> MET gene amplification occurs in 5-15% of patients with acquired resistance to EGFR TKIs. MET activation maintains downstream PI3K/AKT and MAPK signaling despite EGFR inhibition. Combination of EGFR and MET inhibitors shows clinical benefit in this subset.</p>
        </div>
    </div>

    <!-- Slide 5: Combination Strategies -->
    <div class="slide">
        <div class="subtitle">Combination Therapy Strategies</div>
        
        <div class="diagram-container">
            <svg class="detail-svg" viewBox="0 0 800 350">
                <!-- Strategy 1: Vertical Blockade -->
                <g transform="translate(150, 80)">
                    <text x="0" y="-20" text-anchor="middle" font-size="14" font-weight="bold" fill="#4CAF50">Vertical Blockade</text>
                    
                    <rect class="normal-receptor" x="-15" y="0" width="30" height="40" rx="5"/>
                    <circle class="drug-molecule" cx="-40" cy="20" r="10"/>
                    <text x="-40" y="24" fill="white" font-size="9" font-weight="600">D1</text>
                    
                    <circle cx="0" cy="70" r="12" fill="#5088d4" stroke="white" stroke-width="2"/>
                    <path class="arrow" d="M0,40 L0,58" marker-end="url(#arrowhead)"/>
                    
                    <circle cx="0" cy="110" r="12" fill="#5088d4" stroke="white" stroke-width="2"/>
                    <circle class="drug-molecule" cx="30" cy="110" r="10" fill="#5088d4"/>
                    <text x="30" y="114" fill="white" font-size="9" font-weight="600">D2</text>
                    <path class="arrow" d="M0,82 L0,98" marker-end="url(#arrowhead)"/>
                    
                    <circle cx="0" cy="150" r="12" fill="#5088d4" stroke="white" stroke-width="2"/>
                    <path class="arrow" d="M0,122 L0,138" marker-end="url(#arrowhead)"/>
                    
                    <text x="0" y="190" text-anchor="middle" font-size="11" fill="#666">Same pathway</text>
                    <text x="0" y="205" text-anchor="middle" font-size="11" fill="#666">Multiple levels</text>
                </g>
                
                <!-- Strategy 2: Horizontal Blockade -->
                <g transform="translate(400, 80)">
                    <text x="0" y="-20" text-anchor="middle" font-size="14" font-weight="bold" fill="#5088d4">Horizontal Blockade</text>
                    
                    <rect class="normal-receptor" x="-50" y="0" width="30" height="40" rx="5"/>
                    <circle class="drug-molecule" cx="-75" cy="20" r="10"/>
                    <text x="-75" y="24" fill="white" font-size="9" font-weight="600">D1</text>
                    
                    <rect class="normal-receptor" x="20" y="0" width="30" height="40" rx="5"/>
                    <circle class="drug-molecule" cx="75" cy="20" r="10" fill="#5088d4"/>
                    <text x="75" y="24" fill="white" font-size="9" font-weight="600">D2</text>
                    
                    <path class="arrow" d="M-35,40 Q0,60 35,40" stroke-width="2" marker-end="url(#arrowhead)"/>
                    
                    <circle cx="0" cy="110" r="15" fill="#5088d4" stroke="white" stroke-width="2"/>
                    <text x="0" y="115" text-anchor="middle" fill="white" font-size="10" font-weight="600">Signal</text>
                    
                    <text x="0" y="190" text-anchor="middle" font-size="11" fill="#666">Multiple pathways</text>
                    <text x="0" y="205" text-anchor="middle" font-size="11" fill="#666">Same level</text>
                </g>
                
                <!-- Strategy 3: Targeted + Immune -->
                <g transform="translate(650, 80)">
                    <text x="0" y="-20" text-anchor="middle" font-size="14" font-weight="bold" fill="#ffa500">Targeted + Immune</text>
                    
                    <circle cx="0" cy="40" r="30" fill="#ff6b6b" opacity="0.7" stroke="white" stroke-width="2"/>
                    <text x="0" y="45" text-anchor="middle" fill="white" font-weight="600" font-size="11">Tumor</text>
                    
                    <circle class="drug-molecule" cx="-50" cy="40" r="10"/>
                    <text x="-50" y="44" fill="white" font-size="9" font-weight="600">TKI</text>
                    
                    <circle cx="50" cy="40" r="18" fill="#4CAF50" stroke="white" stroke-width="2"/>
                    <text x="50" y="38" text-anchor="middle" fill="white" font-size="8" font-weight="600">T</text>
                    <text x="50" y="47" text-anchor="middle" fill="white" font-size="8" font-weight="600">Cell</text>
                    
                    <circle class="drug-molecule" cx="50" cy="75" r="10" fill="#9c27b0"/>
                    <text x="50" y="79" fill="white" font-size="8" font-weight="600">ICI</text>
                    
                    <text x="0" y="130" text-anchor="middle" font-size="11" fill="#666">Direct killing +</text>
                    <text x="0" y="145" text-anchor="middle" font-size="11" fill="#666">Immune activation</text>
                </g>
                
                <!-- Bottom section: Benefits -->
                <g transform="translate(0, 250)">
                    <rect x="50" y="0" width="700" height="80" rx="10" fill="#e8f8e8" stroke="#4CAF50" stroke-width="2"/>
                    
                    <text x="400" y="25" text-anchor="middle" font-size="15" font-weight="bold" fill="#4CAF50">Benefits of Combination Therapy</text>
                    
                    <g transform="translate(80, 40)">
                        <circle cx="0" cy="0" r="4" fill="#4CAF50"/>
                        <text x="15" y="4" font-size="12">Delay or prevent resistance emergence</text>
                    </g>
                    
                    <g transform="translate(320, 40)">
                        <circle cx="0" cy="0" r="4" fill="#4CAF50"/>
                        <text x="15" y="4" font-size="12">Target multiple resistance mechanisms</text>
                    </g>
                    
                    <g transform="translate(580, 40)">
                        <circle cx="0" cy="0" r="4" fill="#4CAF50"/>
                        <text x="15" y="4" font-size="12">Deeper responses</text>
                    </g>
                    
                    <g transform="translate(80, 60)">
                        <circle cx="0" cy="0" r="4" fill="#4CAF50"/>
                        <text x="15" y="4" font-size="12">Synergistic efficacy</text>
                    </g>
                    
                    <g transform="translate(320, 60)">
                        <circle cx="0" cy="0" r="4" fill="#4CAF50"/>
                        <text x="15" y="4" font-size="12">Address tumor heterogeneity</text>
                    </g>
                </g>
            </svg>
        </div>
        
        <div class="content-grid">
            <div class="detail-box combo">
                <h3>Combination Approaches</h3>
                <ul>
                    <li>Vertical: Target multiple nodes in same pathway</li>
                    <li>Horizontal: Inhibit parallel signaling pathways</li>
                    <li>Targeted + Chemo: Overcome different resistance types</li>
                    <li>Targeted + Immune: Direct + immune-mediated killing</li>
                </ul>
            </div>
            
            <div class="detail-box combo">
                <h3>Clinical Considerations</h3>
                <ul>
                    <li>Increased toxicity requiring dose adjustments</li>
                    <li>Cost and access considerations</li>
                    <li>Biomarker-driven selection of combinations</li>
                    <li>Sequential vs. concurrent administration</li>
                </ul>
            </div>
        </div>
        
        <div class="example-box">
            <h4>Clinical Example</h4>
            <p><strong>Dabrafenib + Trametinib in BRAF V600E Melanoma:</strong> Combined BRAF and MEK inhibition (vertical blockade) significantly improves progression-free survival compared to BRAF inhibitor alone (11 vs 7 months median PFS). The combination delays resistance by preventing feedback reactivation of the MAPK pathway and reduces paradoxical MAPK activation.</p>
        </div>
    </div>

    <!-- Slide 6: Summary -->
    <div class="slide">
        <div class="title">Resistance Mechanisms: Summary & Clinical Impact</div>
        
        <div class="content-grid" style="margin-top: 30px;">
            <div class="detail-box primary">
                <h3>ðŸ”’ Primary Resistance</h3>
                <ul>
                    <li><strong>Timing:</strong> Present before treatment</li>
                    <li><strong>Frequency:</strong> 20-30% of patients</li>
                    <li><strong>Strategy:</strong> Upfront biomarker testing, alternative therapies</li>
                </ul>
            </div>
            
            <div class="detail-box acquired">
                <h3>ðŸ”„ Acquired Resistance</h3>
                <ul>
                    <li><strong>Timing:</strong> Develops during therapy</li>
                    <li><strong>Frequency:</strong> Nearly universal (6-24 months)</li>
                    <li><strong>Strategy:</strong> Resistance profiling, sequential therapies</li>
                </ul>
            </div>
            
            <div class="detail-box bypass">
                <h3>ðŸ”€ Bypass Pathways</h3>
                <ul>
                    <li><strong>Mechanism:</strong> Alternative signaling activation</li>
                    <li><strong>Frequency:</strong> 15-25% of resistance cases</li>
                    <li><strong>Strategy:</strong> Horizontal combination therapy</li>
                </ul>
            </div>
            
            <div class="detail-box combo">
                <h3>ðŸ’Š Combination Strategy</h3>
                <ul>
                    <li><strong>Goal:</strong> Prevent/delay resistance</li>
                    <li><strong>Approaches:</strong> Vertical, horizontal, multi-modal</li>
                    <li><strong>Challenge:</strong> Toxicity management</li>
                </ul>
            </div>
        </div>
        
        <div style="margin-top: 30px; background: #f8f9fb; padding: 20px; border-radius: 10px; border: 2px solid #1E64C8;">
            <h3 style="color: #1E64C8; font-size: 18px; margin-bottom: 15px; text-align: center;">Clinical Decision Framework</h3>
            
            <div style="display: grid; grid-template-columns: 1fr 1fr 1fr; gap: 15px; margin-top: 15px;">
                <div style="text-align: center;">
                    <div style="background: #1E64C8; color: white; padding: 10px; border-radius: 8px; font-weight: 600; margin-bottom: 8px;">
                        Initial Assessment
                    </div>
                    <div style="font-size: 13px; line-height: 1.5;">
                        â€¢ Comprehensive genomic profiling<br>
                        â€¢ Tumor heterogeneity evaluation<br>
                        â€¢ Baseline resistance screening
                    </div>
                </div>
                
                <div style="text-align: center;">
                    <div style="background: #ffa500; color: white; padding: 10px; border-radius: 8px; font-weight: 600; margin-bottom: 8px;">
                        Monitoring
                    </div>
                    <div style="font-size: 13px; line-height: 1.5;">
                        â€¢ Serial liquid biopsy (ctDNA)<br>
                        â€¢ Radiologic response tracking<br>
                        â€¢ Resistance biomarker surveillance
                    </div>
                </div>
                
                <div style="text-align: center;">
                    <div style="background: #4CAF50; color: white; padding: 10px; border-radius: 8px; font-weight: 600; margin-bottom: 8px;">
                        Progression Strategy
                    </div>
                    <div style="font-size: 13px; line-height: 1.5;">
                        â€¢ Re-biopsy for mechanism<br>
                        â€¢ Mechanism-directed therapy<br>
                        â€¢ Clinical trial consideration
                    </div>
                </div>
            </div>
        </div>
        
        <div class="highlight-box" style="margin-top: 25px;">
            <strong>Key Takeaway:</strong> Understanding resistance mechanisms guides rational therapy selection, optimal sequencing strategies, and novel combination approaches to improve patient outcomes in targeted cancer therapy.
        </div>
    </div>

</body>
</html>